คำอธิบาย
Phenytoin reduces topiramate plasma levels via enzyme induction, potentially compromising seizure control when topiramate is added to phenytoin therapy.
กลไก
Phenytoin is a potent CYP3A4 and CYP2C19 inducer that increases topiramate metabolic clearance by approximately 48%.
ความสำคัญทางคลินิก
Topiramate levels may be halved by phenytoin co-administration; dose adjustments are typically required to maintain therapeutic effect.
การจัดการ
Monitor seizure control and topiramate levels; titrate topiramate to therapeutic effect with awareness of enhanced clearance.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.